Rezumat TESLOIANU ANDA - Gr.T. Popa

49. Cabrol S, Sou za R, Jais X, et al. Intravenous epoprostenol in
inoperable chronic th ro mb oembolic pulmon ary h yp ertension. J Heart Lung
Transplant 2007; 26: 357 –362.
50. Olschewski H, Simonneau G, Galie N, et al. Inhaled iloprost in severe
pulmonary h yperten sion. N Engl J Med 2002; 347: 322 –329.
51. Higenbottam T, Butt AY, McMahon A, et al. Lon g-term intravenous
prostaglandin (epoprostenol or iloprost) for treatment of severe pulmon ary
h yperten sion. Heart 1998; 80: 151 –155.
52. Simonneau G, Barst RJ, Galie N, et al. Continuo us subcutaneou s
infu sion o f treprostinil, a prostacyclin an alo gue, in patients with
pulmonary arterial h ypertension. A double -blind, ran domized, placebo -
controlled trial. Am J Resp ir Crit Ca re Med 2002; 165: 800 –804.
53. Barst RJ, Galie N, Naeije R, et al . Long-term outco me in pulmon ary
arterial h yperten sion patients treated with sub cutan eous trep rostinil. Eur
Respir J 2006; 28: 1195 –1203.
54. Lang I, Go mez-San chez M, Kn eussl M, et al. Efficacy o f lon g-term
subcutan eous trepro stinil sodiu m th erap y in pulmon ary h yp ertension.
Chest 2006; 129: 1636 –1643.
55. Tapson VF, Go mb erg-Maitland M, McLau ghlin VV, et al. Safety and
efficacy o f IV trep rostinil for pulmonary arterial h y p ertension: a
prospective, multicenter, open -lab el, 12-week trial. Chest 2006; 129: 683 –
688.
56. McLau ghlin V, Rubin L, Ben za RL, et al. TRIUMPH I: efficacy and
safety o f inhaled treprostinil sodiu m in p atients with pulmon ary arterial
h yperten sion. Am J Respir Crit Care Med 2009; 177: A965.
57. Galie N, Hu mbert M, Vachiery JL, et al. Effects of b eraprost sodiu m,
an oral prostacyclin analogue, in patients with pulmonary arterial
h yperten sion: a rando mised, double -blind placebo -co ntrolled trial. J Am
Coll Cardiol 2002; 39: 14 96 –1502.
58. Giaid A, Yanagisawa M, Lan gleb en D, et al. Expression o f endothelin -1
in the lungs o f p atients with pulmonary h yperten sion . N Engl J Med 1993;
328: 1732–1739.
59. Channick RN, Simonn eau G, Sitbon O, et al. Effects o f th e du al
endothelin-recepto r antago nist bosentan in p atients with pulmonary
h yperten sion: a rando mised placebo -controlled stud y. Lancet 2001; 358:
1119–1123.
60. Rubin LJ, Badesch DB, Barst RJ, et al. Bosentan therap y for pulmon ary
arterial h yperten sion. N Engl J Med 2002; 346: 896 –903.
34